3.Advances in surgical treatment of ischemic cerebrovascular disease.
Journal of Zhejiang University. Medical sciences 2019;48(3):233-240
Restoration of cerebral blood flow is particularly important for the treatment of ischemic cerebrovascular disease. It is notable that surgical approaches play a unique role in treating this devastating disease. Among them, mechanical thrombectomy facilitates rapid and effective recanalization of occluded intracranial large vessels causing ischemic stroke, which contributes to improvement of cerebral perfusion in the ischemic penumbra; decompressive craniectomy is an important therapeutic option for acute massive cerebral infarction, and the timing of surgery determines the final clinical outcomes; for carotid endarterectomy in carotid-artery stenosis, individualized surgical plan is important for the safety and effectiveness of the operation; in the surgical revascularization of Moyamoya disease, precise evaluation of clinical and radiological characteristics, optimal surgical strategies and accuracy of intraoperative judgment will yield maximal therapeutic effects; and hybrid surgery is feasible for the therapy of complex ischemic cerebrovascular diseases, such as extracranial/intracranial arteries tandem stenosis and symptomatic chronic total occlusion of carotid artery. This paper reviews recent technical and clinical advances in the surgical treatment of ischemic cerebrovascular disease.
Brain Ischemia
;
surgery
;
Carotid Artery, Internal
;
surgery
;
Carotid Stenosis
;
surgery
;
Endarterectomy, Carotid
;
trends
;
Humans
;
Stroke
;
surgery
;
Treatment Outcome
4.Outcome of catheter ablation of atrial fibrillation in patients with prior ischemic stroke.
Song-Nan LI ; Jun-Ping KANG ; Xin DU ; Xiao-Nan HE ; De-Yong LONG ; Rong-Hui YU ; Ri-Bo TANG ; Cai-Hua SANG ; Chen-Xi JIANG ; Man NING ; Jian-Zeng DONG ; Chang-Sheng MA
Chinese Medical Journal 2013;126(6):1033-1038
BACKGROUNDCatheter ablation for atrial fibrillation (AF) has been demonstrated to be effective in a subsets of patients with AF. However, very few data are available in regard to patients with prior history of stroke undergoing catheter ablation. This study aimed to investigate the outcome of catheter ablation in AF patients with prior ischemic stroke.
METHODSBetween January 2008 and December 2011, of 1897 consecutive patients who presented at Beijing An Zhen Hospital for treatment of drug-refractory AF, 172 (9.1%) patients in the study population had a history of ischemic stroke. All patients underwent catheter ablation and were followed up to assess maintenance of sinus rhythm and recurrence of symptomatic stroke.
RESULTSAmong these 1897 patients, 1768 (93.2%) who had complete follow-up information for a minimum of six months were included in the final analysis. Patients in the stroke group (group I) and the no-stroke group (group II) were similar in regards to gender, body mass index (BMI), history of diabetes, type of AF, and left atrial size. The patients in group I were older than those in group II, and had a higher incidence of hypertension, chronic heart failure, lower left ventricular ejection fraction (LVEF), and higher CHADS2 scores. Six months after ablation, 107 (68.6%) patients in group I and 1403 (87.1%) in group II had discontinued warfarin treatment (P < 0.001). During a median follow-up of (633 ± 415) days, 65 patients in the group I and 638 in group II experienced AF recurrence, and five patients in group I and 28 in group II developed symptomatic stroke. The rates of AF recurrence and recurrent stroke were similar between group I and group II (41.7% vs. 39.6%, P = 0.611; 3.2% vs. 1.7%, P = 0.219; respectively).
CONCLUSIONCatheter ablation of AF in patients with prior stroke is feasible and efficient.
Aged ; Atrial Fibrillation ; surgery ; Catheter Ablation ; methods ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Stroke ; surgery
5.Application status and prospects of thrombectomy devices for acute ischemic stroke.
Qingshun XU ; Qiaorong JIN ; Zunzhang NI ; Zhiyong XIE ; Qiyi LUO
Chinese Journal of Medical Instrumentation 2013;37(4):274-290
The character and application status of interventional thrombectomy devices for acute ischemic stroke (AIS) are briefly introduced and the development trend is also analyzed.
Brain Ischemia
;
drug therapy
;
surgery
;
Humans
;
Stroke
;
drug therapy
;
surgery
;
Thrombectomy
;
instrumentation
;
Thrombolytic Therapy
;
instrumentation
6.Definition, prediction, prevention and management of patients with severe ischemic stroke and large infarction.
Xing HUA ; Ming LIU ; Simiao WU
Chinese Medical Journal 2023;136(24):2912-2922
Severe ischemic stroke carries a high rate of disability and death. The severity of stroke is often assessed by the degree of neurological deficits or the extent of brain infarct, defined as severe stroke and large infarction, respectively. Critically severe stroke is a life-threatening condition that requires neurocritical care or neurosurgical intervention, which includes stroke with malignant brain edema, a leading cause of death during the acute phase, and stroke with severe complications of other vital systems. Early prediction of high-risk patients with critically severe stroke would inform early prevention and treatment to interrupt the malignant course to fatal status. Selected patients with severe stroke could benefit from intravenous thrombolysis and endovascular treatment in improving functional outcome. There is insufficient evidence to inform dual antiplatelet therapy and the timing of anticoagulation initiation after severe stroke. Decompressive hemicraniectomy (DHC) <48 h improves survival in patients aged <60 years with large hemispheric infarction. Studies are ongoing to provide evidence to inform more precise prediction of malignant brain edema, optimal indications for acute reperfusion therapies and neurosurgery, and the individualized management of complications and secondary prevention. We present an evidence-based review for severe ischemic stroke, with the aims of proposing operational definitions, emphasizing the importance of early prediction and prevention of the evolution to critically severe status, summarizing specialized treatment for severe stroke, and proposing directions for future research.
Humans
;
Ischemic Stroke/pathology*
;
Brain Edema/surgery*
;
Stroke/prevention & control*
;
Brain/pathology*
;
Brain Infarction/pathology*
;
Treatment Outcome
7.Effect of controlled hypotension on predicting transfusion response and threshold of stroke variability in hypertensive patients undergoing robotic hepatobiliary surgery.
Zhe XU ; Xuecai LÜ ; Qiang FU ; Yi LIU ; Rong LIU ; Weidong MI
Journal of Central South University(Medical Sciences) 2019;44(4):419-425
To investigate the effect of controlled hypotension by urapidil on the predictive accuracy and diagnostic threshold of stroke volume variation (SVV) in hypertensive and non-hypertensive patients undergoing robotic hepatobiliary surgery.
Methods: Eighty patients undergoing robotic hepatobiliary surgery under general anesthesia were divided into a hypertension group (n=25) and a non-hypertension group (n=38) according to whether or not essential hypertension was present (excluding some cases that didn't meet requirements). The pump speed was at 6.0-7.0 µg/(kg﹒min), and the range of hypotension was between 10%≤Δ systolic blood pressure (SAP)≤20%. Volume loading test was performed after artificial pneumoperitoneum was established in reverse-Trendelenburg position. Hemodynamic indexes including heart rate (HR), SAP, cardiac output (CO), cardiac index (CI), stroke volume (SV), stroke volume index (SVI) and SVV were recorded before and after infusion. Then the receiver operating characteristic (ROC) curves of SVV was drawn to determine the accuracy and diagnosis of SVV in predicting volume status in hypertensive and non-hypertensive patients after anti-Trendelenburg posture and pneumoperitoneum.
Results: In the patients with controlled hypotension by urapidil, the area under the ROC curve of SVV in the hypertension group was 0.974, the diagnostic threshold was 13.5%, the ROC curve of SVV in the non-hypertension group was 0.832, and the diagnostic threshold was 15.5%.
Conclusion: SVV can accurately predict the volume status in the hypertension group and the non-hypertension group after controlled hypotension in the anti-Trendelenburg position and fixed pneumoperitoneal pressure, and the SVV diagnostic threshold in the non-hypertensive group is higher than that in the hypertensive group.
Biliary Tract Diseases
;
surgery
;
Blood Pressure
;
Cardiac Output
;
Fluid Therapy
;
Hemodynamics
;
Humans
;
Hypotension, Controlled
;
Liver Diseases
;
surgery
;
ROC Curve
;
Robotic Surgical Procedures
;
Stroke
;
Stroke Volume
8.Percutaneous left atrial appendage occlusion therapy in a female recurrent ischemic stroke patient with persistent atrial fibrillation and moyamoya disease.
Song ZUO ; Jia Hui WU ; Xiao Wen BO ; Xin ZHAO ; Xu LI ; Song Nan LI ; Jian Zeng DONG ; Chang Sheng MA
Chinese Journal of Cardiology 2020;48(11):982-984
9.Measurement of Right Ventricular Ejection Fraction(RVEF) in Patients Undergoing Cardiac Surgery.
Jin Yun KIM ; Hong Seok YANG ; Sun Gyoo PARK
Korean Journal of Anesthesiology 1993;26(4):706-713
The left ventricle is realized as the cardiac structure of greatest importance for cardiac pump function, and the role of the right ventricle has been overlooked. However, the right ventricle and the left ventricle are in series and physiologically coupled so that a disturbance in the one ventricular function will influence the behavior of the other. Thus, there ia growing interest in the importance of the right side of the heart, particularly in patients undergoing cardiac surgery. Moreover recently, right ventricular failure has been identified as a cause of progressive deterioration in patients undergoing cardiac operations, and it may limit the overall success of the procedure. This study was performed to investigate right ventricular ejection fraction of the cardiac patients at pre and post-perfusion period. 10 cases were measured and analyzed. The results were as follows: I) There were no singificant differences statistically in demographic data of the patients. 2) Pulmonary capillary wedge pressure(PCWP) of postperfusion 10 min. was significantly increased compared to preperfusion period(p<0.01). 3) Systemic vascular resistance(SVR) of immediate postperfusion period was significantly decreased compared to preperfusion period. 4) Heart rate and central venous pressure(CVP) of postperfusion period were statistically significantly increased, but clinically no significant change compared to preperfusion period. 5) Cardiac output(CO) and right ventricular ejection fraction(RVEF) of postperfusion period were no significant change compared to preperfusion period.
Capillaries
;
Heart
;
Heart Rate
;
Heart Ventricles
;
Humans
;
Stroke Volume
;
Thoracic Surgery*
;
Ventricular Function
10.Surgical Management of Infective Endocarditis Complicated by Embolic Stroke: Early versus Delayed Surgery.
Gwan Sic KIM ; Joon Bum KIM ; Sung Ho JUNG ; Tae Jin YUN ; Suk Jung CHOO ; Cheol Hyun CHUNG ; Jae Won LEE
The Korean Journal of Thoracic and Cardiovascular Surgery 2011;44(5):332-337
BACKGROUND: The optimal timing of surgery for infective endocarditis complicated by embolic stroke is unclear. We compared early versus delayed surgery in these patients. MATERIALS AND METHODS: Between 1992 and 2007, 56 consecutive patients underwent open cardiac surgery for the treatment of infective endocarditis complicated by acute septic embolic stroke, 34 within 2 weeks (early group) and 22 more than 2 weeks (delayed group) after the onset of stroke. RESULTS: The mean age at time of surgery was 45.7+/-14.8 years. Stroke was ischemic in 42 patients and hemorrhagic in 14. Patients in the early group were more likely to have highly mobile, large (>1 cm in diameter) vegetation and less likely to have hemorrhagic infarction than those in the delayed group. There were two (3.7%) intraoperative deaths, both in the early group and attributed to neurologic aggravation. Among the 54 survivors, 4 (7.1%), that is, 2 in each group, showed neurologic aggravation. During a median follow-up of 61.7 months (range, 0.4~170.4 months), there were 5 late deaths. Overall 5-year neurologic aggravation-free survival rates were 79.1+/-7.0% in the early group and 90.9+/-6.1% in the delayed group (p=0.113). CONCLUSION: Outcomes of early operation for infective endocarditis in stroke patients were similar to those of the conventional approach. Early surgical intervention may be preferable for patients at high risk of life-threatening septic embolism.
Embolism
;
Endocarditis
;
Follow-Up Studies
;
Humans
;
Infarction
;
Neurologic Manifestations
;
Stroke
;
Survival Rate
;
Survivors
;
Thoracic Surgery